TheraRadar
← Back
Data updated: Mar 29, 2026

PH HEALTH

CardiovascularNeurologyInfectious Disease
Generics

PH HEALTH is a generic drug manufacturer focused on Cardiovascular, Neurology, Infectious Disease. Key products include MICAFUNGIN.

1947
Since
157
Drugs
-
Trials
1749
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 41%
14 drugs
Neurology 21%
7 drugs
Infectious Disease 18%
6 drugs
Metabolic 12%
4 drugs
Respiratory 9%
3 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...